Two Sigma Investments, LP Kura Oncology, Inc. Transaction History

Two Sigma Investments, LP

$41.6 Billion
Q4 2024

A detailed history of Two Sigma Investments, LP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 166,119 shares of KURA stock, worth $1.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

166,119

Previous 208,239 20.23%

Holding current value

$1.37 Million

Previous $4.07 Million 64.45%

% of portfolio

0.0%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$8.51 - $19.21 $358,441 - $809,125	-42,120 Reduced 20.23%	166,119 $1.45 Million
Q3 2024 Nov 14, 2024	SELL	$18.57 - $23.23 $1.19 Million - $1.49 Million	-64,035 Reduced 23.52%	208,239 $4.07 Million
Q2 2024 Aug 14, 2024	BUY	$17.53 - $22.98 $1.66 Million - $2.17 Million	94,624 Added 53.26%	272,274 $5.61 Million
Q1 2024 May 15, 2024	BUY	$13.42 - $23.53 $2.38 Million - $4.18 Million	177,650 New	177,650 $3.79 Million
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $1.96 Million - $3.17 Million	163,239 Added 177.63%	255,139 $3.49 Million
Q2 2022 Aug 15, 2022	SELL	$10.71 - $18.33 $582,334 - $996,657	-54,373 Reduced 37.17%	91,900 $1.69 Million
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $4.2 Million - $6.05 Million	-356,554 Reduced 70.91%	146,273 $2.35 Million
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $1.08 Million - $1.74 Million	88,672 Added 21.41%	502,827 $7.04 Million
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $5.74 Million - $8.09 Million	-372,272 Reduced 47.34%	414,155 $7.76 Million
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $3.71 Million - $5.32 Million	178,144 Added 29.29%	786,427 $16.4 Million
Q1 2021 May 17, 2021	BUY	$24.75 - $39.14 $603,083 - $953,724	24,367 Added 4.17%	608,283 $17.2 Million
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $16.5 Million - $23.7 Million	568,716 Added 3741.55%	583,916 $19.1 Million
Q3 2020 Nov 16, 2020	SELL	$16.3 - $30.64 $1.93 Million - $3.63 Million	-118,312 Reduced 88.62%	15,200 $466,000
Q2 2020 Aug 14, 2020	SELL	$7.95 - $18.81 $256,451 - $606,772	-32,258 Reduced 19.46%	133,512 $2.18 Million
Q1 2020 May 15, 2020	SELL	$6.45 - $14.04 $94,511 - $205,728	-14,653 Reduced 8.12%	165,770 $1.65 Million
Q4 2019 Feb 14, 2020	BUY	$12.97 - $15.94 $1.51 Million - $1.86 Million	116,777 Added 183.48%	180,423 $2.48 Million
Q3 2019 Nov 14, 2019	SELL	$14.75 - $20.87 $343,026 - $485,352	-23,256 Reduced 26.76%	63,646 $966,000
Q2 2019 Aug 14, 2019	BUY	$14.71 - $19.79 $275,474 - $370,607	18,727 Added 27.47%	86,902 $1.71 Million
Q1 2019 May 15, 2019	BUY	$13.73 - $16.87 $936,042 - $1.15 Million	68,175 New	68,175 $1.13 Million
Q4 2018 Feb 14, 2019	SELL	$10.6 - $17.49 $201,686 - $332,782	-19,027 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.65 - $21.85 $316,799 - $415,739	19,027 New	19,027 $333,000
Q2 2018 Aug 14, 2018	SELL	$14.8 - $18.8 $573,411 - $728,387	-38,744 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$14.5 - $23.4 $561,788 - $906,609	38,744 New	38,744 $726,000

Others Institutions Holding KURA

# of Institutions

193

Shares Held

77.5M

Call Options Held

103K

Put Options Held

106K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $552M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Kura Oncology, Inc. Transaction History